Ratos Valuation
Is RAZB undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of RAZB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: RAZB (€2.77) is trading below our estimate of fair value (€4.28)
Significantly Below Fair Value: RAZB is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RAZB?
Key metric: As RAZB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is RAZB's PE Ratio? | |
|---|---|
| PE Ratio | 11.1x |
| Earnings | SEK 957.00m |
| Market Cap | SEK 10.82b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.6x |
| Enterprise Value/EBITDA | 11.1x |
| PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does RAZB's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 13.5x | ||
MLP MLP | 9.9x | 8.3% | €640.5m |
AR4 AURELIUS Equity Opportunities SE KGaA | 3.9x | n/a | €390.6m |
O4B OVB Holding | 15.3x | 3.5% | €282.2m |
DBAN Deutsche Beteiligungs | 24.7x | 54.1% | €426.4m |
RAZB Ratos | 11.1x | 18.1% | €10.8b |
Price-To-Earnings vs Peers: RAZB is good value based on its Price-To-Earnings Ratio (11.1x) compared to the peer average (13.5x).
Price to Earnings Ratio vs Industry
How does RAZB's PE Ratio compare vs other companies in the DE Capital Markets Industry?
| 4 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
AR4 AURELIUS Equity Opportunities SE KGaA | 3.9x | n/a | US$409.25m |
HXCK Ernst Russ | 3.7x | -18.2% | US$202.59m |
VG8 Varengold Bank | 1.8x | n/a | US$24.24m |
XE8 Black Sea Property | 0.7x | n/a | US$7.74m |
| 4 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: RAZB is good value based on its Price-To-Earnings Ratio (11.1x) compared to the German Capital Markets industry average (20.3x).
Price to Earnings Ratio vs Fair Ratio
What is RAZB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 11.1x |
| Fair PE Ratio | 15x |
Price-To-Earnings vs Fair Ratio: RAZB is good value based on its Price-To-Earnings Ratio (11.1x) compared to the estimated Fair Price-To-Earnings Ratio (15x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €2.77 | €3.63 +31.2% | 9.5% | €3.98 | €3.28 | n/a | 2 |
| Nov ’25 | €2.91 | €3.68 +26.4% | 9.5% | €4.03 | €3.33 | n/a | 2 |
| Oct ’25 | €3.05 | €3.56 +16.6% | 8.4% | €3.86 | €3.26 | n/a | 2 |
| Sep ’25 | €3.00 | €3.56 +18.7% | 8.4% | €3.86 | €3.26 | n/a | 2 |
| Aug ’25 | €2.95 | €3.56 +20.5% | 8.4% | €3.86 | €3.26 | n/a | 2 |
| Jul ’25 | €3.15 | €3.61 +14.8% | 10.6% | €4.00 | €3.23 | n/a | 2 |
| Jun ’25 | €3.43 | €3.61 +5.5% | 10.6% | €4.00 | €3.23 | n/a | 2 |
| May ’25 | €3.23 | €3.61 +12.0% | 10.6% | €4.00 | €3.23 | n/a | 2 |
| Apr ’25 | €2.97 | €3.70 +24.9% | 9.5% | €4.06 | €3.35 | n/a | 2 |
| Mar ’25 | €3.07 | €3.70 +20.8% | 9.5% | €4.06 | €3.35 | n/a | 2 |
| Feb ’25 | €3.06 | €3.86 +26.0% | 11.6% | €4.30 | €3.41 | n/a | 2 |
| Jan ’25 | €3.26 | €3.86 +18.4% | 11.6% | €4.30 | €3.41 | n/a | 2 |
| Dec ’24 | €2.78 | €3.79 +36.3% | 10.6% | €4.08 | €3.23 | n/a | 3 |
| Nov ’24 | €2.60 | €3.79 +45.6% | 10.6% | €4.08 | €3.23 | €2.91 | 3 |
| Oct ’24 | €2.78 | €3.97 +42.7% | 13.4% | €4.60 | €3.30 | €3.05 | 3 |
| Sep ’24 | €2.83 | €3.97 +40.1% | 13.4% | €4.60 | €3.30 | €3.00 | 3 |
| Aug ’24 | €3.00 | €3.97 +32.2% | 13.4% | €4.60 | €3.30 | €2.95 | 3 |
| Jul ’24 | €2.51 | €4.19 +67.1% | 16.4% | €5.04 | €3.36 | €3.15 | 3 |
| Jun ’24 | €2.68 | €4.19 +56.4% | 16.4% | €5.04 | €3.36 | €3.43 | 3 |
| May ’24 | €3.03 | €4.19 +38.2% | 16.4% | €5.04 | €3.36 | €3.23 | 3 |
| Apr ’24 | €2.76 | €4.22 +53.0% | 14.1% | €4.89 | €3.44 | €2.97 | 3 |
| Mar ’24 | €2.95 | €4.22 +42.9% | 14.1% | €4.89 | €3.44 | €3.07 | 3 |
| Feb ’24 | €3.69 | €4.53 +22.7% | 18.5% | €5.33 | €3.38 | €3.06 | 3 |
| Jan ’24 | €3.74 | €4.79 +28.1% | 19.4% | €5.49 | €3.48 | €3.26 | 3 |
| Dec ’23 | €4.16 | €4.79 +15.1% | 19.4% | €5.49 | €3.48 | €2.78 | 3 |
| Nov ’23 | €3.79 | €4.79 +26.3% | 19.4% | €5.49 | €3.48 | €2.60 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.
Discover undervalued companies
ORIX
JP¥3.8t
Provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East.
OIX
JP¥20.40
7D
1.0%
1Y
22.2%
Mutares SE KGaA
€484.6m
A private equity firm specializing in investments in secondary direct, special situations, bridge financing, recapitalization, distressed/vulture, management succession, reorganization, carve-outs, turnarounds, spin-offs and re-funding.
MUX
€22.40
7D
1.1%
1Y
-29.3%
Merchants Bancorp
US$1.9b
Operates as the diversified bank holding company in the United States.
3KD
US$39.20
7D
5.9%
1Y
31.5%